Recent findings indicate that a CD44 variant enhances ROS defense in cancer cells through interaction with and stabilization of xCT, which is the cell surface cystine transporter subunit, thereby promoting tumor growth [35,36]. The gene discussed is SLC7A11; the disease is cancer.